Horan Capital Advisors. buys $2,496,703 stake in Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific (TMO) : Horan Capital Advisors. scooped up 160 additional shares in Thermo Fisher Scientific during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 10, 2016. The investment management firm now holds a total of 16,057 shares of Thermo Fisher Scientific which is valued at $2,496,703.Thermo Fisher Scientific makes up approximately 1.91% of Horan Capital Advisors.’s portfolio.

Other Hedge Funds, Including , First Mercantile Trust Co reduced its stake in TMO by selling 595 shares or 14.89% in the most recent quarter. The Hedge Fund company now holds 3,400 shares of TMO which is valued at $528,666. Thermo Fisher Scientific makes up approx 0.06% of First Mercantile Trust Co’s portfolio.Gamco Investors Et Al reduced its stake in TMO by selling 175 shares or 0.53% in the most recent quarter. The Hedge Fund company now holds 32,545 shares of TMO which is valued at $5,126,163. Thermo Fisher Scientific makes up approx 0.03% of Gamco Investors Et Al’s portfolio.Stralem Co Inc reduced its stake in TMO by selling 11,475 shares or 8.24% in the most recent quarter. The Hedge Fund company now holds 127,785 shares of TMO which is valued at $20,150,417. Thermo Fisher Scientific makes up approx 2.28% of Stralem Co Inc’s portfolio.Premier Asset Managment reduced its stake in TMO by selling 2,345 shares or 2.71% in the most recent quarter. The Hedge Fund company now holds 84,295 shares of TMO which is valued at $13,292,479. Thermo Fisher Scientific makes up approx 3.25% of Premier Asset Managment’s portfolio.Burns J W Co Incny reduced its stake in TMO by selling 35 shares or 0.24% in the most recent quarter. The Hedge Fund company now holds 14,817 shares of TMO which is valued at $2,327,010. Thermo Fisher Scientific makes up approx 0.69% of Burns J W Co Incny’s portfolio.

Thermo Fisher Scientific opened for trading at $152.88 and hit $153.81 on the upside on Friday, eventually ending the session at $153.58, with a gain of 0.15% or 0.23 points. The heightened volatility saw the trading volume jump to 14,98,018 shares. Company has a market cap of $60,551 M.

On the company’s financial health, Thermo Fisher Scientific reported $2.03 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $2.01. The company had revenue of $4535.20 million for the quarter, compared to analysts expectations of $4493.28 million. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 EPS.

Investors should note that on Jul 7, 2016, Thermo Fisher Scientific announced a cash dividend of $0.1500. The company’s management has announced Sep 13, 2016 as the ex-dividend date and fixed the record date on Sep 15, 2016. The payable date has been fixed on Oct 17, 2016.

Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 27, 2016 to “Buy”, Firm has raised the Price Target to $ 170 from a previous price target of $166 .Company shares were Reiterated by Mizuho on May 19, 2016 to “Buy”, Firm has raised the Price Target to $ 166 from a previous price target of $163 .

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.